• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

导丝和器械相关的 III 级冠状动脉穿孔(来自 G3CAP- Cardiogroup VI 注册研究)的发生率、处理、即刻和长期结果。

Incidence, Management, Immediate and Long-Term Outcome of Guidewire and Device Related Grade III Coronary Perforations (from G3CAP - Cardiogroup VI Registry).

机构信息

Interventional Cardiology Unit, San Luigi Gonzaga University Hospital (Orbassano) and Rivoli Infermi Hospital (Rivoli), Turin, Italy; Montefiore Medical Center, New York, New York.

Cardiology Unit, Santissima Annunziata Hospital, ASL CN1, Savigliano (CN), Italy.

出版信息

Am J Cardiol. 2021 Mar 15;143:37-45. doi: 10.1016/j.amjcard.2020.12.041. Epub 2020 Dec 30.

DOI:10.1016/j.amjcard.2020.12.041
PMID:33387472
Abstract

Ellis grade III coronary artery perforations (G3-CAP) remain a life-threatening complication of percutaneous coronary intervention (PCI), with high morbidity and mortality and lack of consensus regarding optimal treatment strategies. We reviewed all PCIs performed in 10 European centers from 1993 to 2019 recording all G3-CAP along with management strategies, in-hospital and long-term outcome according to Device-related perforations (DP) and Guidewire-related perforations (WP). Among 106,592 PCI (including 7,773 chronic total occlusions), G3-CAP occurred in 311 patients (0.29%). DP occurred in 194 cases (62.4%), more commonly in proximal segments (73.2%) and frequently secondary to balloon dilatation (66.0%). WP arose in 117 patients (37.6%) with chronic total occlusions guidewires involved in 61.3% of cases. Overall sealing success rate was 90.7% and usually required multiple maneuvers (80.4%). The most commonly adopted strategies to obtain hemostasis were prolonged balloon inflation (73.2%) with covered stent implantation (64.4%) in the DP group, and prolonged balloon inflation (53.8%) with coil embolization (41%) in the WP group.  Procedural or in-hospital events arose in 38.2% of cases: mortality was higher after DP (7.2% vs 2.6%, p = 0.05) and acute stent thrombosis 3-fold higher (3.1% vs 0.9%, p = 0.19). At clinical follow-up, median 2 years, a major cardiovascular event occurred in one-third of cases (all-cause mortality 8.2% and 7.1% respectively, without differences between groups). In conclusion, although rare and despite improved rates of adequate perforation sealing G3-CAP cause significant adverse events. DP and WP result in different patterns of G3-CAP and management strategies should be based on this classification.

摘要

III 级(Ellis 分级)冠状动脉穿孔(G3-CAP)仍然是经皮冠状动脉介入治疗(PCI)的一种危及生命的并发症,具有较高的发病率和死亡率,并且对于最佳治疗策略缺乏共识。我们回顾了 1993 年至 2019 年在 10 个欧洲中心进行的所有 PCI,记录了所有 G3-CAP 以及根据器械相关穿孔(DP)和导丝相关穿孔(WP)的管理策略、住院期间和长期结果。在 106592 例 PCI(包括 7773 例慢性完全闭塞)中,311 例患者出现 G3-CAP(0.29%)。DP 发生在 194 例患者中(62.4%),更常见于近端节段(73.2%),常继发于球囊扩张(66.0%)。WP 发生在 117 例患者中(37.6%),其中 61.3%的病例涉及慢性完全闭塞导丝。总体封堵成功率为 90.7%,通常需要多次操作(80.4%)。最常采用的止血策略是 DP 组延长球囊扩张(73.2%)联合覆膜支架植入(64.4%),WP 组延长球囊扩张(53.8%)联合线圈栓塞(41%)。38.2%的病例出现了操作或住院期间的事件:DP 后死亡率更高(7.2%比 2.6%,p=0.05),急性支架血栓形成的风险增加 3 倍(3.1%比 0.9%,p=0.19)。在临床随访中,中位 2 年,三分之一的病例发生了主要心血管事件(全因死亡率分别为 8.2%和 7.1%,两组之间无差异)。总之,尽管 G3-CAP 罕见,且尽管穿孔封堵的成功率有所提高,但仍会导致严重的不良事件。DP 和 WP 导致不同类型的 G3-CAP,应根据这一分类制定治疗策略。

相似文献

1
Incidence, Management, Immediate and Long-Term Outcome of Guidewire and Device Related Grade III Coronary Perforations (from G3CAP - Cardiogroup VI Registry).导丝和器械相关的 III 级冠状动脉穿孔(来自 G3CAP- Cardiogroup VI 注册研究)的发生率、处理、即刻和长期结果。
Am J Cardiol. 2021 Mar 15;143:37-45. doi: 10.1016/j.amjcard.2020.12.041. Epub 2020 Dec 30.
2
Acute and long-term outcomes after polytetrafluoroethylene or pericardium covered stenting for grade 3 coronary artery perforations: Insights from G3-CAP registry.聚四氟乙烯或心包覆盖支架治疗 3 级冠状动脉穿孔的急性和长期结果:来自 G3-CAP 登记的结果。
Catheter Cardiovasc Interv. 2018 Dec 1;92(7):1247-1255. doi: 10.1002/ccd.27789. Epub 2018 Sep 23.
3
Coronary artery perforation during chronic total occlusion percutaneous coronary intervention: epidemiology, mechanisms, management, and outcomes.冠状动脉慢性完全闭塞介入治疗中发生的冠状动脉穿孔:流行病学、机制、处理和结果。
EuroIntervention. 2019 Oct 4;15(9):e804-e811. doi: 10.4244/EIJ-D-19-00282.
4
"Incidence, clinical and angiographic characteristics, management and outcomes of coronary artery perforation at a high volume cardiac care center during percutaneous coronary intervention"."在高容量心脏护理中心进行经皮冠状动脉介入治疗期间冠状动脉穿孔的发生率、临床和血管造影特征、处理和结局"。
Indian Heart J. 2020 Jul-Aug;72(4):232-238. doi: 10.1016/j.ihj.2020.07.012. Epub 2020 Jul 17.
5
Prevalence and Predictors of Coronary Artery Perforation During Percutaneous Coronary Interventions (from the ORPKI National Registry in Poland).经皮冠状动脉介入治疗期间冠状动脉穿孔的发生率及预测因素(来自波兰的 ORPKI 国家注册中心)。
Am J Cardiol. 2019 Oct 15;124(8):1186-1189. doi: 10.1016/j.amjcard.2019.07.021. Epub 2019 Jul 25.
6
Clinical Characteristics and Management of Coronary Artery Perforations: A Single-Center 11-Year Experience and Practical Overview.冠状动脉穿孔的临床特征和处理:单中心 11 年经验及实用综述。
J Am Heart Assoc. 2017 Sep 22;6(9):e007049. doi: 10.1161/JAHA.117.007049.
7
Incidence, predictors, management, immediate and long-term outcomes following grade III coronary perforation.III 级冠状动脉穿孔的发生率、预测因素、处理、即刻和长期结局。
JACC Cardiovasc Interv. 2011 Jan;4(1):87-95. doi: 10.1016/j.jcin.2010.08.026.
8
Incidence, Treatment, and Outcomes of Coronary Perforation During Chronic Total Occlusion Percutaneous Coronary Intervention.慢性完全闭塞性经皮冠状动脉介入治疗期间冠状动脉穿孔的发生率、治疗及结局
Am J Cardiol. 2017 Oct 15;120(8):1285-1292. doi: 10.1016/j.amjcard.2017.07.010. Epub 2017 Jul 24.
9
Incidence, Mechanisms, Treatment, and Outcomes of Coronary Artery Perforation During Chronic Total Occlusion Percutaneous Coronary Intervention.慢性完全闭塞经皮冠状动脉介入治疗中冠状动脉穿孔的发生率、机制、治疗和转归。
Am J Cardiol. 2022 Nov 1;182:17-24. doi: 10.1016/j.amjcard.2022.07.004. Epub 2022 Aug 24.
10
Novel approach to coronary artery perforation repair.冠状动脉穿孔修复的新方法。
Catheter Cardiovasc Interv. 2019 Feb 1;93(2):E98-E100. doi: 10.1002/ccd.27849. Epub 2018 Sep 9.

引用本文的文献

1
Clinical Experience With a Novel Perfusion Balloon Catheter in Patients With Coronary Artery Perforation: Primary Results From the Ringer Clinical Study.新型灌注球囊导管在冠状动脉穿孔患者中的临床经验:林格临床研究的初步结果
J Soc Cardiovasc Angiogr Interv. 2025 Jul 22;4(7):103575. doi: 10.1016/j.jscai.2025.103575. eCollection 2025 Jul.
2
Bail-Out Techniques in Percutaneous Intervention for Ellis Grade III Coronary Perforation in Left Main Distal Bifurcation Lesions.左主干远端分叉病变中 Ellis Ⅲ级冠状动脉穿孔经皮介入治疗中的补救技术
J Soc Cardiovasc Angiogr Interv. 2023 Mar 11;2(3):100609. doi: 10.1016/j.jscai.2023.100609. eCollection 2023 May-Jun.
3
Embolization of Perforated Coronary Artery with a Fragment of Balloon Catheter (Cut Balloon Technique)-Multicenter Study.
使用球囊导管碎片栓塞穿孔冠状动脉(切割球囊技术)-多中心研究
J Cardiovasc Dev Dis. 2023 Dec 14;10(12):496. doi: 10.3390/jcdd10120496.
4
Efficacy and safety of self-made covered coronary stent in the treatment of coronary artery perforation.自制覆盖式冠状动脉支架治疗冠状动脉穿孔的疗效及安全性。
BMC Cardiovasc Disord. 2023 Nov 4;23(1):537. doi: 10.1186/s12872-023-03575-3.
5
Intra- and Postprocedural Management of Coronary Artery Perforation During Percutaneous Coronary Intervention.经皮冠状动脉介入治疗期间冠状动脉穿孔的术中及术后管理
Circ Rep. 2022 Oct 13;4(11):517-525. doi: 10.1253/circrep.CR-22-0092. eCollection 2022 Nov 10.
6
Procedural and 1-year outcomes following large vessel coronary artery perforation treated by covered stents implantation: Multicentre CRACK registry.大血管冠状动脉穿孔患者应用带膜支架植入治疗的操作程序和 1 年结果:多中心 CRACK 注册研究。
PLoS One. 2021 May 12;16(5):e0249698. doi: 10.1371/journal.pone.0249698. eCollection 2021.